Veeva Systems (BSP:V2EE34) ROCE % : 11.62% (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Veeva Systems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Veeva Systems's annualized ROCE % for the quarter that ended in Jan. 2024 was 11.62%.

Veeva Systems ROCE % Historical Data

The historical data trend for Veeva Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veeva Systems ROCE % Chart

Veeva Systems Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

ROCE %

Get a 7-Day Free Trial

20.10

20.64

19.30

13.18

9.82

Veeva Systems Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															11.89	6.20	9.88	12.14	11.62

Veeva Systems ROCE % Calculation

Veeva Systems's annualized ROCE % for the fiscal year that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	2111.55	/	( ( (24944.866 - 5227.523)	+	(29071.087 - 5797.982) )	/ 2 )
	=	2111.55	/	( (19717.343	+	23273.105)	/ 2 )
	=	2111.55	/	21495.224
	=	9.82 %

Veeva Systems's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	2661.02	/	( ( (26420.981 - 3884.195)	+	(29071.087 - 5797.982) )	/ 2 )
	=	2661.02	/	( ( 22536.786	+	23273.105 )	/ 2 )
	=	2661.02	/	22904.9455
	=	11.62 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Veeva Systems (BSP:V2EE34) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Veeva Systems ROCE % Related Terms

Thank you for viewing the detailed overview of Veeva Systems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Veeva Systems (BSP:V2EE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veeva Systems Inc (BSP:V2EE34) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VEEV:USA VEEV:Mexico VEE:Germany VEEV:Austria

Address

4280 Hacienda Drive, Pleasanton, CA, USA, 94588

Website

https://www.veeva.com

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Veeva Systems (BSP:V2EE34) Headlines

No Headlines